Advertisement
UK markets close in 2 hours 3 minutes
  • FTSE 100

    7,669.46
    +39.44 (+0.52%)
     
  • FTSE 250

    19,246.96
    +192.09 (+1.01%)
     
  • AIM

    738.88
    +2.38 (+0.32%)
     
  • GBP/EUR

    1.1674
    -0.0008 (-0.07%)
     
  • GBP/USD

    1.2625
    -0.0001 (-0.01%)
     
  • Bitcoin GBP

    49,351.55
    -540.25 (-1.08%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,096.27
    +26.51 (+0.52%)
     
  • DOW

    38,996.39
    +47.37 (+0.12%)
     
  • CRUDE OIL

    79.63
    +1.37 (+1.75%)
     
  • GOLD FUTURES

    2,064.10
    +9.40 (+0.46%)
     
  • NIKKEI 225

    39,910.82
    +744.63 (+1.90%)
     
  • HANG SENG

    16,589.44
    +78.00 (+0.47%)
     
  • DAX

    17,737.12
    +58.93 (+0.33%)
     
  • CAC 40

    7,930.28
    +2.85 (+0.04%)
     

Global Patient Blood Management Market to Reach $23.6 Billion by 2030

ReportLinker
ReportLinker

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, May 16, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Patient Blood Management Industry" - https://www.reportlinker.com/p06032450/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Patient Blood Management Market to Reach $23.6 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Patient Blood Management estimated at US$13.3 Billion in the year 2022, is projected to reach a revised size of US$23.6 Billion by 2030, growing at aCAGR of 7.5% over the period 2022-2030. Instruments, one of the segments analyzed in the report, is projected to record 7.6% CAGR and reach US$10.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Reagents & Kits segment is readjusted to a revised 8.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.6 Billion, While China is Forecast to Grow at 12.2% CAGR

The Patient Blood Management market in the U.S. is estimated at US$3.6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2030 trailing a CAGR of 12.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 6.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Select Competitors (Total 42 Featured)
- Abbott Laboratories
- Asahi Kasei Medical Co. Ltd.
- B. Braun Melsungen AG
- Biomérieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- F. Hoffmann-La Roche LTD.
- Fresenius Se & Co. KGaA
- Grifols, S.A.
- Haemonetics Corporation
- Immucor, Inc.
- Kaneka Corporation
- Livanova PLC
- Macopharma
- Terumo Corporation


Read the full report: https://www.reportlinker.com/p06032450/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Patient Blood Management - Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Patient Blood Management by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Patient Blood Management by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 3: World 16-Year Perspective for Patient Blood Management
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Instruments by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 6: World 16-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Reagents & Kits by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 8: World Historic Review for Reagents & Kits by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 9: World 16-Year Perspective for Reagents & Kits by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Software by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 11: World Historic Review for Software by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 12: World 16-Year Perspective for Software by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Accessories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 14: World Historic Review for Accessories by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 15: World 16-Year Perspective for Accessories by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Whole Blood & Red Blood Cells by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 17: World Historic Review for Whole Blood & Red Blood
Cells by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 18: World 16-Year Perspective for Whole Blood & Red Blood
Cells by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030

Table 19: World Recent Past, Current & Future Analysis for
Plasma by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 20: World Historic Review for Plasma by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 21: World 16-Year Perspective for Plasma by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Blood Banks by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 23: World Historic Review for Blood Banks by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 24: World 16-Year Perspective for Blood Banks by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 25: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 26: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 27: World 16-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 28: World Patient Blood Management Market Analysis of
Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
Patient Blood Management Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2023 (E)
Table 29: USA Recent Past, Current & Future Analysis for
Patient Blood Management by Product - Instruments, Reagents &
Kits, Software and Accessories - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 30: USA Historic Review for Patient Blood Management by
Product - Instruments, Reagents & Kits, Software and
Accessories Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 31: USA 16-Year Perspective for Patient Blood Management
by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits, Software and Accessories for the
Years 2014, 2023 & 2030

Table 32: USA Recent Past, Current & Future Analysis for
Patient Blood Management by Component - Whole Blood & Red Blood
Cells and Plasma - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 33: USA Historic Review for Patient Blood Management by
Component - Whole Blood & Red Blood Cells and Plasma Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 34: USA 16-Year Perspective for Patient Blood Management
by Component - Percentage Breakdown of Value Sales for Whole
Blood & Red Blood Cells and Plasma for the Years 2014, 2023 &
2030

Table 35: USA Recent Past, Current & Future Analysis for
Patient Blood Management by End-Use - Blood Banks and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 36: USA Historic Review for Patient Blood Management by
End-Use - Blood Banks and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 37: USA 16-Year Perspective for Patient Blood Management
by End-Use - Percentage Breakdown of Value Sales for Blood
Banks and Hospitals for the Years 2014, 2023 & 2030

CANADA
Table 38: Canada Recent Past, Current & Future Analysis for
Patient Blood Management by Product - Instruments, Reagents &
Kits, Software and Accessories - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 39: Canada Historic Review for Patient Blood Management
by Product - Instruments, Reagents & Kits, Software and
Accessories Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 40: Canada 16-Year Perspective for Patient Blood
Management by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits, Software and Accessories for the
Years 2014, 2023 & 2030

Table 41: Canada Recent Past, Current & Future Analysis for
Patient Blood Management by Component - Whole Blood & Red Blood
Cells and Plasma - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 42: Canada Historic Review for Patient Blood Management
by Component - Whole Blood & Red Blood Cells and Plasma Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 43: Canada 16-Year Perspective for Patient Blood
Management by Component - Percentage Breakdown of Value Sales
for Whole Blood & Red Blood Cells and Plasma for the Years
2014, 2023 & 2030

Table 44: Canada Recent Past, Current & Future Analysis for
Patient Blood Management by End-Use - Blood Banks and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 45: Canada Historic Review for Patient Blood Management
by End-Use - Blood Banks and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 46: Canada 16-Year Perspective for Patient Blood
Management by End-Use - Percentage Breakdown of Value Sales for
Blood Banks and Hospitals for the Years 2014, 2023 & 2030

JAPAN
Patient Blood Management Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2023 (E)
Table 47: Japan Recent Past, Current & Future Analysis for
Patient Blood Management by Product - Instruments, Reagents &
Kits, Software and Accessories - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 48: Japan Historic Review for Patient Blood Management by
Product - Instruments, Reagents & Kits, Software and
Accessories Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 49: Japan 16-Year Perspective for Patient Blood
Management by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits, Software and Accessories for the
Years 2014, 2023 & 2030

Table 50: Japan Recent Past, Current & Future Analysis for
Patient Blood Management by Component - Whole Blood & Red Blood
Cells and Plasma - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 51: Japan Historic Review for Patient Blood Management by
Component - Whole Blood & Red Blood Cells and Plasma Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 52: Japan 16-Year Perspective for Patient Blood
Management by Component - Percentage Breakdown of Value Sales
for Whole Blood & Red Blood Cells and Plasma for the Years
2014, 2023 & 2030

Table 53: Japan Recent Past, Current & Future Analysis for
Patient Blood Management by End-Use - Blood Banks and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 54: Japan Historic Review for Patient Blood Management by
End-Use - Blood Banks and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 55: Japan 16-Year Perspective for Patient Blood
Management by End-Use - Percentage Breakdown of Value Sales for
Blood Banks and Hospitals for the Years 2014, 2023 & 2030

CHINA
Patient Blood Management Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2023 (E)
Table 56: China Recent Past, Current & Future Analysis for
Patient Blood Management by Product - Instruments, Reagents &
Kits, Software and Accessories - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 57: China Historic Review for Patient Blood Management by
Product - Instruments, Reagents & Kits, Software and
Accessories Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 58: China 16-Year Perspective for Patient Blood
Management by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits, Software and Accessories for the
Years 2014, 2023 & 2030

Table 59: China Recent Past, Current & Future Analysis for
Patient Blood Management by Component - Whole Blood & Red Blood
Cells and Plasma - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 60: China Historic Review for Patient Blood Management by
Component - Whole Blood & Red Blood Cells and Plasma Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 61: China 16-Year Perspective for Patient Blood
Management by Component - Percentage Breakdown of Value Sales
for Whole Blood & Red Blood Cells and Plasma for the Years
2014, 2023 & 2030

Table 62: China Recent Past, Current & Future Analysis for
Patient Blood Management by End-Use - Blood Banks and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 63: China Historic Review for Patient Blood Management by
End-Use - Blood Banks and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 64: China 16-Year Perspective for Patient Blood
Management by End-Use - Percentage Breakdown of Value Sales for
Blood Banks and Hospitals for the Years 2014, 2023 & 2030

EUROPE
Patient Blood Management Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2023 (E)
Table 65: Europe Recent Past, Current & Future Analysis for
Patient Blood Management by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 66: Europe Historic Review for Patient Blood Management
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 67: Europe 16-Year Perspective for Patient Blood
Management by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2014, 2023 & 2030

Table 68: Europe Recent Past, Current & Future Analysis for
Patient Blood Management by Product - Instruments, Reagents &
Kits, Software and Accessories - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 69: Europe Historic Review for Patient Blood Management
by Product - Instruments, Reagents & Kits, Software and
Accessories Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 70: Europe 16-Year Perspective for Patient Blood
Management by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits, Software and Accessories for the
Years 2014, 2023 & 2030

Table 71: Europe Recent Past, Current & Future Analysis for
Patient Blood Management by Component - Whole Blood & Red Blood
Cells and Plasma - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 72: Europe Historic Review for Patient Blood Management
by Component - Whole Blood & Red Blood Cells and Plasma Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 73: Europe 16-Year Perspective for Patient Blood
Management by Component - Percentage Breakdown of Value Sales
for Whole Blood & Red Blood Cells and Plasma for the Years
2014, 2023 & 2030

Table 74: Europe Recent Past, Current & Future Analysis for
Patient Blood Management by End-Use - Blood Banks and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 75: Europe Historic Review for Patient Blood Management
by End-Use - Blood Banks and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 76: Europe 16-Year Perspective for Patient Blood
Management by End-Use - Percentage Breakdown of Value Sales for
Blood Banks and Hospitals for the Years 2014, 2023 & 2030

FRANCE
Patient Blood Management Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2023 (E)
Table 77: France Recent Past, Current & Future Analysis for
Patient Blood Management by Product - Instruments, Reagents &
Kits, Software and Accessories - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 78: France Historic Review for Patient Blood Management
by Product - Instruments, Reagents & Kits, Software and
Accessories Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 79: France 16-Year Perspective for Patient Blood
Management by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits, Software and Accessories for the
Years 2014, 2023 & 2030

Table 80: France Recent Past, Current & Future Analysis for
Patient Blood Management by Component - Whole Blood & Red Blood
Cells and Plasma - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 81: France Historic Review for Patient Blood Management
by Component - Whole Blood & Red Blood Cells and Plasma Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 82: France 16-Year Perspective for Patient Blood
Management by Component - Percentage Breakdown of Value Sales
for Whole Blood & Red Blood Cells and Plasma for the Years
2014, 2023 & 2030

Table 83: France Recent Past, Current & Future Analysis for
Patient Blood Management by End-Use - Blood Banks and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 84: France Historic Review for Patient Blood Management
by End-Use - Blood Banks and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 85: France 16-Year Perspective for Patient Blood
Management by End-Use - Percentage Breakdown of Value Sales for
Blood Banks and Hospitals for the Years 2014, 2023 & 2030

GERMANY
Patient Blood Management Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2023 (E)
Table 86: Germany Recent Past, Current & Future Analysis for
Patient Blood Management by Product - Instruments, Reagents &
Kits, Software and Accessories - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 87: Germany Historic Review for Patient Blood Management
by Product - Instruments, Reagents & Kits, Software and
Accessories Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 88: Germany 16-Year Perspective for Patient Blood
Management by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits, Software and Accessories for the
Years 2014, 2023 & 2030

Table 89: Germany Recent Past, Current & Future Analysis for
Patient Blood Management by Component - Whole Blood & Red Blood
Cells and Plasma - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 90: Germany Historic Review for Patient Blood Management
by Component - Whole Blood & Red Blood Cells and Plasma Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 91: Germany 16-Year Perspective for Patient Blood
Management by Component - Percentage Breakdown of Value Sales
for Whole Blood & Red Blood Cells and Plasma for the Years
2014, 2023 & 2030

Table 92: Germany Recent Past, Current & Future Analysis for
Patient Blood Management by End-Use - Blood Banks and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 93: Germany Historic Review for Patient Blood Management
by End-Use - Blood Banks and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 94: Germany 16-Year Perspective for Patient Blood
Management by End-Use - Percentage Breakdown of Value Sales for
Blood Banks and Hospitals for the Years 2014, 2023 & 2030

ITALY
Table 95: Italy Recent Past, Current & Future Analysis for
Patient Blood Management by Product - Instruments, Reagents &
Kits, Software and Accessories - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 96: Italy Historic Review for Patient Blood Management by
Product - Instruments, Reagents & Kits, Software and
Accessories Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 97: Italy 16-Year Perspective for Patient Blood
Management by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits, Software and Accessories for the
Years 2014, 2023 & 2030

Table 98: Italy Recent Past, Current & Future Analysis for
Patient Blood Management by Component - Whole Blood & Red Blood
Cells and Plasma - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 99: Italy Historic Review for Patient Blood Management by
Component - Whole Blood & Red Blood Cells and Plasma Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 100: Italy 16-Year Perspective for Patient Blood
Management by Component - Percentage Breakdown of Value Sales
for Whole Blood & Red Blood Cells and Plasma for the Years
2014, 2023 & 2030

Table 101: Italy Recent Past, Current & Future Analysis for
Patient Blood Management by End-Use - Blood Banks and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 102: Italy Historic Review for Patient Blood Management
by End-Use - Blood Banks and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 103: Italy 16-Year Perspective for Patient Blood
Management by End-Use - Percentage Breakdown of Value Sales for
Blood Banks and Hospitals for the Years 2014, 2023 & 2030

UNITED KINGDOM
Patient Blood Management Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 104: UK Recent Past, Current & Future Analysis for
Patient Blood Management by Product - Instruments, Reagents &
Kits, Software and Accessories - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 105: UK Historic Review for Patient Blood Management by
Product - Instruments, Reagents & Kits, Software and
Accessories Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 106: UK 16-Year Perspective for Patient Blood Management
by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits, Software and Accessories for the
Years 2014, 2023 & 2030

Table 107: UK Recent Past, Current & Future Analysis for
Patient Blood Management by Component - Whole Blood & Red Blood
Cells and Plasma - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 108: UK Historic Review for Patient Blood Management by
Component - Whole Blood & Red Blood Cells and Plasma Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 109: UK 16-Year Perspective for Patient Blood Management
by Component - Percentage Breakdown of Value Sales for Whole
Blood & Red Blood Cells and Plasma for the Years 2014, 2023 &
2030

Table 110: UK Recent Past, Current & Future Analysis for
Patient Blood Management by End-Use - Blood Banks and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 111: UK Historic Review for Patient Blood Management by
End-Use - Blood Banks and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 112: UK 16-Year Perspective for Patient Blood Management
by End-Use - Percentage Breakdown of Value Sales for Blood
Banks and Hospitals for the Years 2014, 2023 & 2030

SPAIN
Table 113: Spain Recent Past, Current & Future Analysis for
Patient Blood Management by Product - Instruments, Reagents &
Kits, Software and Accessories - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 114: Spain Historic Review for Patient Blood Management
by Product - Instruments, Reagents & Kits, Software and
Accessories Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 115: Spain 16-Year Perspective for Patient Blood
Management by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits, Software and Accessories for the
Years 2014, 2023 & 2030

Table 116: Spain Recent Past, Current & Future Analysis for
Patient Blood Management by Component - Whole Blood & Red Blood
Cells and Plasma - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 117: Spain Historic Review for Patient Blood Management
by Component - Whole Blood & Red Blood Cells and Plasma Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 118: Spain 16-Year Perspective for Patient Blood
Management by Component - Percentage Breakdown of Value Sales
for Whole Blood & Red Blood Cells and Plasma for the Years
2014, 2023 & 2030

Table 119: Spain Recent Past, Current & Future Analysis for
Patient Blood Management by End-Use - Blood Banks and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 120: Spain Historic Review for Patient Blood Management
by End-Use - Blood Banks and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 121: Spain 16-Year Perspective for Patient Blood
Management by End-Use - Percentage Breakdown of Value Sales for
Blood Banks and Hospitals for the Years 2014, 2023 & 2030

RUSSIA
Table 122: Russia Recent Past, Current & Future Analysis for
Patient Blood Management by Product - Instruments, Reagents &
Kits, Software and Accessories - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 123: Russia Historic Review for Patient Blood Management
by Product - Instruments, Reagents & Kits, Software and
Accessories Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 124: Russia 16-Year Perspective for Patient Blood
Management by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits, Software and Accessories for the
Years 2014, 2023 & 2030

Table 125: Russia Recent Past, Current & Future Analysis for
Patient Blood Management by Component - Whole Blood & Red Blood
Cells and Plasma - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 126: Russia Historic Review for Patient Blood Management
by Component - Whole Blood & Red Blood Cells and Plasma Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 127: Russia 16-Year Perspective for Patient Blood
Management by Component - Percentage Breakdown of Value Sales
for Whole Blood & Red Blood Cells and Plasma for the Years
2014, 2023 & 2030

Table 128: Russia Recent Past, Current & Future Analysis for
Patient Blood Management by End-Use - Blood Banks and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 129: Russia Historic Review for Patient Blood Management
by End-Use - Blood Banks and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 130: Russia 16-Year Perspective for Patient Blood
Management by End-Use - Percentage Breakdown of Value Sales for
Blood Banks and Hospitals for the Years 2014, 2023 & 2030

REST OF EUROPE
Table 131: Rest of Europe Recent Past, Current & Future
Analysis for Patient Blood Management by Product - Instruments,
Reagents & Kits, Software and Accessories - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 132: Rest of Europe Historic Review for Patient Blood
Management by Product - Instruments, Reagents & Kits, Software
and Accessories Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2014 through 2021 and % CAGR

Table 133: Rest of Europe 16-Year Perspective for Patient Blood
Management by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits, Software and Accessories for the
Years 2014, 2023 & 2030

Table 134: Rest of Europe Recent Past, Current & Future
Analysis for Patient Blood Management by Component - Whole
Blood & Red Blood Cells and Plasma - Independent Analysis of

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032450/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001